Mustang Bio (MBIO) Non Operating Interest Expenses (2016 - 2024)

Mustang Bio (MBIO) has reported Non Operating Interest Expenses for 9 consecutive years, with $1000.0 the latest figure, recorded in Q4 2024.

• On a quarterly basis, Non Operating Interest Expenses rose 133.33% year-over-year to $1000.0 in Q4 2024; TTM through Dec 2024 was $5000.0, a 99.88% decrease from a year earlier, with the FY2024 full-year figure at $5000.0, down 99.88% from the prior year.
• Non Operating Interest Expenses was $1000.0 for Q4 2024 at Mustang Bio, roughly flat from $1000.0 in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $2.9 million in Q2 2023 and troughed at -$3000.0 in Q4 2023.
• A 5-year average of $570250.0 and a median of $7500.0 in 2020 frame the typical range for Non Operating Interest Expenses.
• Across the five-year window, Non Operating Interest Expenses surged 34366.67% in 2022 and slumped 100.26% in 2023, its largest moves.
• Over 5 years, Non Operating Interest Expenses stood at $11000.0 in 2020, then plunged by 63.64% to $4000.0 in 2021, then jumped by 28900.0% to $1.2 million in 2022, then tumbled by 100.26% to -$3000.0 in 2023, then jumped by 133.33% to $1000.0 in 2024.
• The last three Non Operating Interest Expenses figures came in at $1000.0 (Q4 2024), $1000.0 (Q3 2024), and $2000.0 (Q2 2024), per Business Quant data.